Vascular risk profile and changes of arterial hypertension after surgical revascularization in adult Moyamoya patients

被引:1
作者
Haas, Patrick [1 ,2 ]
Wiggenhauser, Lucas Moritz [1 ,2 ]
Tellermann, Jonas [1 ,2 ]
Hurth, Helene [1 ,2 ]
Feucht, Daniel [1 ,2 ]
Tatagiba, Marcos [1 ,2 ]
Khan, Nadia [1 ,2 ,3 ]
Roder, Constantin [1 ,2 ]
机构
[1] Univ Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
[2] Univ Tubingen, Moyamoya Ctr, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
[3] Univ Zurich, Univ Childrens Hosp Zurich, Moyamoya Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland
关键词
Cerebral revascularization; Moyamoya; Arterial hypertension; DISEASE; PREVALENCE; RNF213; HOMOZYGOSITY; ASSOCIATION; STENOSIS; LESIONS;
D O I
10.1038/s41598-024-61966-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Moyamoya disease (MMD) is a rare stenoocclusive cerebral vasculopathy often treated by neurosurgical revascularization using extracranial-intracranial bypasses to prevent ischemic or hemorrhagic events. Little is known about the vascular risk profile of adult MMD patients compared to the general population. We therefore analyzed 133 adult MMD patients and compared them with data from more than 22,000 patients from the German Health Update database. Patients with MMD showed an age- and sex-adjusted increased prevalence of arterial hypertension, especially in women between 30 and 44 years and in patients of both sexes between 45 and 64 years. Diabetes mellitus was diagnosed significantly more frequently in MMD patients with increasing age, whereas the vascular risk profile in terms of obesity, nicotine and alcohol consumption was similar to that of the general population. Antihypertensive medication was changed one year after surgical revascularization in 67.5% of patients with a tendency towards dose reduction in 43.2% of all patients. After revascularization, physicians need to be aware of a high likelihood of changes in arterial hypertension and should adjust all other modifiable systemic vascular risk factors to achieve the best treatment possible.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians [J].
Acker, G. ;
Goerdes, S. ;
Schneider, U. C. ;
Schmiedek, P. ;
Czabanka, M. ;
Vajkoczy, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (06) :1012-1017
[2]   Prevalence and clinical implications of renal artery stenosis in pediatric moyamoya disease [J].
Baek, Jin Wook ;
Jo, Kyung-Il ;
Park, Jeong Jin ;
Jeon, Pyoung ;
Kim, Keon Ha .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2016, 20 (01) :20-24
[3]   European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) [J].
Bersano, Anna ;
Khan, Nadia ;
Fuentes, Blanca ;
Acerbi, Francesco ;
Canavero, Isabella ;
Tournier-Lasserve, Elisabeth ;
Vajcoczy, Peter ;
Zedde, Maria Luisa ;
Hussain, Salman ;
Lemeret, Sabrina ;
Kraemer, Markus ;
Herve, Dominique .
EUROPEAN STROKE JOURNAL, 2023, 8 (01) :55-84
[4]   Moyamoya Disease in a Primarily White, Midwestern US Population Increased Prevalence of Autoimmune Disease [J].
Bower, Regina S. ;
Mallory, Grant W. ;
Nwojo, Macaulay ;
Kudva, Yogish C. ;
Flemming, Kelly D. ;
Meyer, Fredric B. .
STROKE, 2013, 44 (07) :1997-+
[5]   Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co-occurrence of Moyamoya Disease [J].
Chang, Sung-A ;
Song, Ju Sun ;
Park, Taek Kyu ;
Yang, Jeong Hoon ;
Kwon, Woo Chan ;
Kim, So Ree ;
Kim, Sung Mok ;
Cha, Jihoon ;
Jang, Shin Yi ;
Cho, Young Seok ;
Kim, Tae Jung ;
Bang, Oh Young ;
Song, Jin Young ;
Ki, Chang-Seok ;
Kim, Duk-Kyung .
CHEST, 2018, 153 (02) :404-413
[6]   Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population [J].
Chen, Jian-bin ;
Liu, Yi ;
Zhou, Liang-xue ;
Sun, Hong ;
He, Min ;
You, Chao .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 351 (1-2) :184-186
[7]   2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society [J].
Fujimura, Miki ;
Tominaga, Teiji ;
Kuroda, Satoshi ;
Takahashi, Jun C. ;
Endo, Hidenori ;
Ogasawara, Kuniaki ;
Miyamoto, Susumu .
NEUROLOGIA MEDICO-CHIRURGICA, 2022, 62 (04) :165-170
[8]   Homozygosity for Moyamoya Disease Risk Allele Leads to Moyamoya Disease with Extracranial Systemic and Pulmonary Vasculopathy [J].
Fukushima, Hiroyuki ;
Takenouchi, Toshiki ;
Kosaki, Kenjiro .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2016, 170 (09) :2453-2456
[9]   Modifiable Risk Factors Associated With Moyamoya Disease A Case-Control Study [J].
Ge, Peicong ;
Zhang, Qian ;
Ye, Xun ;
Liu, Xingju ;
Deng, Xiaofeng ;
Wang, Jia ;
Wang, Rong ;
Zhang, Yan ;
Zhang, Dong ;
Zhao, Jizong .
STROKE, 2020, 51 (08) :2472-2479
[10]   Diabetes or calcium channel blocker contribute to cerebral hemodynamics after bypass surgery in adult patients with moyamoya disease [J].
Han, Shoumeng ;
Cai, Linzhi ;
Tian, Qi ;
Wei, Heng ;
Wang, Guijun ;
Wang, Jianfeng ;
He, Peibang ;
Liao, Jianming ;
Zhang, Shenqi ;
Chen, Qianxue ;
Li, Mingchang .
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (01) :293-308